Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens

被引:82
作者
Joachim, Stephanie C. [1 ]
Reichelt, Jan [1 ]
Berneiser, Simone [1 ]
Pfeiffer, Norbert [1 ]
Grus, Franz H. [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Dept Ophthalmol, D-55101 Mainz, Germany
关键词
antibody profile; glaucoma; myelin basic protein; optic nerve;
D O I
10.1007/s00417-007-0737-8
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background The aim of this study was to gain more information about the possible immunological mechanisms in glaucoma. We analyzed the complex autoantibody patterns against human optic nerve antigens in sera of patients with glaucoma and tried to identify important antigens. Methods Sera of 133 patients were included: healthy control subjects (n = 44), primary open-angle glaucoma (n = 44), and normal tension glaucoma patients (n = 45). The sera were tested against Western blots of human optic nerve, and antibody bands were visualized with chloronaphthol. IgG antibody patterns were analyzed by multivariate statistical techniques, and the most significant antigens were identified by mass spectrometry (Maldi-TOFTOF). Results All subjects, even healthy ones, showed different and complex antibody patterns. Glaucoma groups showed specific up- and down-regulations of antibody reactivities compared to the control group. The multivariate analysis of discriminance found significant differences (P < 0.05) in IgG antibody profiles against human optic nerve antigens between both glaucoma groups and healthy subjects. The identified antigens include: myelin basic protein (up-regulated in the POAG group), glial fibrillary acidic protein (down-regulated in the glaucoma groups), and vimentin (down-regulated in the glaucoma groups in comparison to controls). Conclusions Using human optic nerve antigen, we were able to demonstrate that complex IgG autoantibody patterns exist in sera of patients with glaucoma. Large correlations between the given and our previous studies using bovine optic nerve antigens could be seen. Furthermore, anti-myelin basic protein antibodies, which can also be detected in patients with multiple sclerosis, were found in sera of glaucoma patients.
引用
收藏
页码:573 / 580
页数:8
相关论文
共 53 条
[1]   Development of autoantibodies before the clinical onset of systemic lupus erythematosus [J].
Arbuckle, MR ;
McClain, MT ;
Rubertone, MV ;
Scofield, RH ;
Dennis, GJ ;
James, JA ;
Harley, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (16) :1526-1533
[2]   Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event [J].
Berger, T ;
Rubner, P ;
Schautzer, F ;
Egg, R ;
Ulmer, H ;
Mayringer, I ;
Dilitz, E ;
Deisenhammer, F ;
Reindl, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) :139-145
[3]  
BROWN C, 1986, J CLIN LAB IMMUNOL, V19, P1
[4]   A rapid ELISA-based serum assay for myelin basic protein in multiple sclerosis [J].
Chamczuk, AJ ;
Ursell, M ;
O'Connor, P ;
Jackowski, G ;
Moscarello, MA .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 262 (1-2) :21-27
[5]   Expression of glial fibrillary acidic protein and glutamine synthetase by Muller cells after optic nerve damage and intravitreal application of brain-derived neurotrophic factor [J].
Chen, A ;
Weber, AJ .
GLIA, 2002, 38 (02) :115-125
[6]   SOME THOUGHTS ON THE STRUCTURAL BASIS OF INTERNAL IMAGERY [J].
ERLANGER, BF .
IMMUNOLOGY TODAY, 1989, 10 (05) :151-152
[7]   The impact of ocular blood flow in glaucoma [J].
Flammer, J ;
Orgül, S ;
Costa, VP ;
Orzalesi, N ;
Krieglstein, GK ;
Serra, LM ;
Renard, JP ;
Stefánsson, E .
PROGRESS IN RETINAL AND EYE RESEARCH, 2002, 21 (04) :359-393
[8]   PROGRAMMED CELL-DEATH OF RETINAL GANGLION-CELLS DURING EXPERIMENTAL GLAUCOMA [J].
GARCIAVALENZUELA, E ;
SHAREEF, S ;
WALSH, J ;
SHARMA, SC .
EXPERIMENTAL EYE RESEARCH, 1995, 61 (01) :33-44
[9]   Serum autoantibodies to α-fodrin are present in glaucoma patients from Germany and the United States [J].
Grus, FH ;
Joachim, SC ;
Bruns, K ;
Lackner, KJ ;
Pfeiffer, N ;
Wax, MB .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (03) :968-976
[10]  
Grus FH, 2004, MOL VIS, V10, P132